Skip to content
Tuesday, April 7, 2026
  • Headlines
  • Business
  • Economy
  • Politics
  • Top News
  • Newsletters
The Cheap Investor

The Cheap Investor

  • Headlines
  • Business
  • Economy
  • Politics
  • Top News
  • Newsletters
The Cheap Investor

The Cheap Investor

  • Headlines
  • Business
  • Economy
  • Politics
  • Top News
  • Newsletters
  • Home
  • 2023
  • April
  • 26
  • Roche Q1 sales decline tempered by swift uptake of new eye drug
  • FILE PHOTO: Logo of Swiss drugmaker Roche is seen in

    FILE PHOTO: Logo of Swiss drugmaker Roche is seen in

    FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann/File Photo

    Post navigation

    Previous: Roche Q1 sales decline tempered by swift uptake of new eye drug

    Live Market Pulse

    The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

    Recent Posts

    • Maker of Stanley tumblers prevails in lawsuit over lead scare
    • Nuclear’s Second Act: Where the Power Market Is Quietly Shifting
    • Special Report: SpaceX and the Potential 2026 IPO
    • Three AI-Infrastructure Stocks the Market Is Mispricing Right Now
    • Snap’s Activist Moment: A Blueprint Nobody Asked For — But Everyone Needed
    • The Easter Gap That Could Break Either Way
    • Alto Ingredients (ALTO): The Corn-to-Cash Machine Nobody Is Talking About
    • Oklo Inc. (OKLO): The Nuclear Bet Behind the AI Power Crisis

    Categories

    • Headlines
    • Business
    • Economy
    • Politics
    • Top News
    • Newsletters

    • Home
    • Disclaimer
    • Contact Us
    • Terms of Service
    • Privacy Policy
    Copyright 2026 © All rights reserved | The Cheap Investor | thecheapinvestor.com
    SITE_OK